Production (Stage)
COSCIENS Biopharma Inc.
CSCI
$3.68
$0.113.08%
NASDAQ
| 03/31/2025 | 06/30/2024 | 06/30/2024 | 03/31/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -16.07% | -5.89% | -5.89% | -13.14% | 342.42% |
| Total Receivables | -24.77% | 339.94% | 339.94% | -10.20% | 6.21% |
| Inventory | -8.77% | 4,673.44% | 4,673.44% | -3.03% | -98.40% |
| Prepaid Expenses | -16.35% | -99.69% | -99.69% | 411.20% | 1,477.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 18.46% | -- | -- | -- | -- |
| Total Current Assets | -15.12% | 6.45% | 6.45% | -14.22% | 176.87% |
|
|
|||||
| Total Current Assets | -15.12% | 6.45% | 6.45% | -14.22% | 176.87% |
| Net Property, Plant & Equipment | -2.80% | 4,143.17% | 4,143.17% | -14.51% | -97.67% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.07% | 514.42% | 514.42% | -1.81% | -60.53% |
| Total Assets | -11.20% | 57.41% | 57.41% | -14.11% | 33.89% |
|
|
|||||
| Total Accounts Payable | 18.65% | 49.25% | 49.25% | 28.72% | 754.80% |
| Total Accrued Expenses | -19.74% | 17.93% | 17.93% | 8.94% | 161.70% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -6.64% | 164.29% | 164.29% | -3.75% | -48.49% |
| Total Finance Division Other Current Liabilities | -5.80% | 366.16% | 366.16% | 3.30% | -- |
| Total Other Current Liabilities | -5.80% | 366.16% | 366.16% | 3.30% | -- |
| Total Current Liabilities | -2.26% | 88.46% | 88.46% | 15.68% | 300.61% |
|
|
|||||
| Total Current Liabilities | -2.26% | 88.46% | 88.46% | 15.68% | 300.61% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.24% | 1,500.00% | 1,500.00% | -32.77% | -94.28% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -5.40% | -6.30% | -6.30% | -4.74% | -- |
| Total Liabilities | -4.16% | 26.54% | 26.54% | 0.01% | 594.54% |
|
|
|||||
| Common Stock & APIC | 0.08% | -92.50% | -92.50% | -23.62% | 2,070.67% |
| Retained Earnings | -21.02% | 100.41% | 100.41% | -1.47% | -8,714.88% |
| Treasury Stock & Other | -17.56% | -97.16% | -97.16% | 2,327.03% | 2,898.86% |
| Total Common Equity | -22.92% | 102.21% | 102.21% | -28.72% | -38.34% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -22.92% | 102.21% | 102.21% | -28.72% | -38.34% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -22.92% | 102.21% | 102.21% | -28.72% | -38.34% |
|
|
|||||